Online Database of Chemicals from Around the World

2-Chloro-5-(difluoromethoxy)pyrimidine
[CAS# 1192813-64-1]

List of Suppliers
MolScanner Singapore Inquire  
+86 18621675448
marketing@molscanner.com
WhatsApp: 9896 7603
Chemical manufacturer since 2025
chemBlink standard supplier since 2025
Complete supplier list of 2-Chloro-5-(difluoromethoxy)pyrimidine
Identification
Classification Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyrimidine compound
Name 2-Chloro-5-(difluoromethoxy)pyrimidine
Molecular Structure CAS # 1192813-64-1, 2-Chloro-5-(difluoromethoxy)pyrimidine
Molecular Formula C5H3ClF2N2O
Molecular Weight 180.54
CAS Registry Number 1192813-64-1
EC Number 823-560-5
SMILES C1=C(C=NC(=N1)Cl)OC(F)F
Properties
Density 1.5±0.1 g/cm3 Calc.*
Boiling point 260.1±30.0 ºC 760 mmHg (Calc.)*
Flash point 111.1±24.6 ºC (Calc.)*
Index of refraction 1.469 (Calc.)*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H312-H315-H319-H332-H335    Details
Precautionary Statements P261-P264-P264+P265-P270-P271-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P317-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
Acute toxicityAcute Tox.4H332
Acute toxicityAcute Tox.4H312
Eye irritationEye Irrit.2AH319
SDS Available
up Discovory and Applicatios
2-Chloro-5-(difluoromethoxy)pyrimidine is a halogenated heterocyclic compound derived from pyrimidine, bearing a chlorine atom at the 2-position and a difluoromethoxy group at the 5-position. Its molecular structure features a six-membered aromatic diazine ring, which includes two nitrogen atoms at the 1 and 3 positions, forming the backbone of numerous biologically active molecules in medicinal and agrochemical research. The substitution pattern imparts distinct electronic and steric characteristics, enhancing its reactivity and functional versatility in synthetic chemistry.

The synthesis and development of substituted pyrimidines such as 2-chloro-5-(difluoromethoxy)pyrimidine emerged from the broader study of nitrogen-containing heterocycles, a core area of interest in pharmaceutical and agrochemical discovery. Halogenated pyrimidines are particularly valued for their role as key intermediates in cross-coupling reactions, nucleophilic substitution, and heterocyclic ring functionalization. The presence of the chlorine atom in the 2-position facilitates such transformations through its ability to serve as a leaving group in reactions catalyzed by transition metals or under basic conditions. Simultaneously, the difluoromethoxy moiety at the 5-position contributes unique electronic properties that affect the compound's polarity and reactivity.

This compound has been used as a precursor or intermediate in the synthesis of more complex molecules, particularly those targeting biological systems such as enzymes, receptors, or nucleic acid-related processes. The difluoromethoxy group is a bioisosteric replacement for hydroxyl or methoxy groups in medicinal chemistry, often used to fine-tune the pharmacokinetic and metabolic profiles of candidate compounds. Its electron-withdrawing nature can alter hydrogen bonding capacity and increase lipophilicity, potentially improving membrane permeability and metabolic stability.

In medicinal chemistry, derivatives of 2-chloro-5-(difluoromethoxy)pyrimidine have been incorporated into structures exhibiting antiviral, antibacterial, and anticancer activities. The pyrimidine scaffold itself is a common structural motif in DNA and RNA bases, and synthetic analogs are frequently designed to interfere with nucleotide processing enzymes, such as kinases or polymerases. Substituted pyrimidines also appear in kinase inhibitors, where specific patterns of substitution influence binding to ATP-binding pockets.

The compound’s synthesis typically involves selective halogenation and subsequent alkylation of appropriately substituted pyrimidine precursors. The introduction of the difluoromethoxy group is achieved through the use of difluorocarbene reagents or difluoromethyl ethers under suitable reaction conditions. The resulting material is usually purified by recrystallization or chromatographic techniques to afford the compound in high purity suitable for further derivatization.

2-Chloro-5-(difluoromethoxy)pyrimidine’s role as a functionalized intermediate makes it attractive for libraries of small molecules in high-throughput screening applications. Its dual reactivity—through the electrophilic 2-chloropyrimidine site and the electron-rich difluoromethoxy substituent—offers multiple points of synthetic elaboration, enabling the construction of structurally diverse analogs with potential biological activity.

In agrochemistry, compounds derived from halogenated pyrimidines have been used in the development of herbicides and fungicides. Their selective bioactivity and favorable environmental stability are often attributed to the properties imparted by fluorinated substituents, which can resist biodegradation and enhance systemic action in plant tissues.

Because of its established reactivity and structural features, 2-chloro-5-(difluoromethoxy)pyrimidine remains a valuable synthetic intermediate in both pharmaceutical and agrochemical research programs.
Market Analysis Reports
List of Reports Available for 2-Chloro-5-(difluoromethoxy)pyrimidine
Related Products
2-Chloro-1,1-difluoroethene  (S)-3-((2-Chloro-5-(2,2-difluoroethyl)-8-fluoro-5H-dibenzo[b,e][1,4]diazepin-11-yl)amino)-N-isopropylpyrrolidine-1-carboxamide  8-Chloro-6,7-difluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid  5-Chloro-1,3-difluoro-2-iodobenzene  6-Chloro-2-(difluoromethoxy)aniline  5-Chloro-1,3-difluoro-2-methoxybenzene  4-Chloro-2-(difluoromethoxy)benzoic acid  N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide  2-Chloro-5-(difluoromethoxy)pyrazine  2-Chloro-6-(difluoromethoxy)pyridine  1-Chloro-4,5-difluoro-2-methylbenzene  (Chlorodifluoromethyl)benzene  4-(4-Chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine  1-(Chlorodifluoromethyl)-2-fluorobenzene  5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxaldehyde  2-Chloro-3-(difluoromethyl)pyridine  2-Chloro-4-(difluoromethyl)pyridine  6-Chloro-3-(difluoromethyl)pyridine  6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine  4-Chloro-3,5-difluoronitrobenzen